| Names | |
|---|---|
| Preferred IUPAC name | (2S)-2-amino-3-methylbutanoic acid |
| Other names | L-2-Aminoisovaleric acid Val Valine 2-Amino-3-methylbutanoic acid |
| Pronunciation | /ˈɛl ˈveɪliːn/ |
| Identifiers | |
| CAS Number | 72-18-4 |
| Beilstein Reference | 1720803 |
| ChEBI | CHEBI:16414 |
| ChEMBL | CHEMBL1087 |
| ChemSpider | 595 |
| DrugBank | DB00161 |
| ECHA InfoCard | 100.067.407 |
| EC Number | 2.6.1.9 |
| Gmelin Reference | 1543 |
| KEGG | C00183 |
| MeSH | D014637 |
| PubChem CID | 6287 |
| RTECS number | YV9620000 |
| UNII | 9DNS0M82MA |
| UN number | UN3335 |
| CompTox Dashboard (EPA) | DTXSID2023166 |
| Properties | |
| Chemical formula | C5H11NO2 |
| Molar mass | 117.15 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 0.8 g/cm³ |
| Solubility in water | 8.8 g/100 mL (25 °C) |
| log P | -2.094 |
| Vapor pressure | 0.0 mmHg (approx) |
| Acidity (pKa) | 2.32 |
| Basicity (pKb) | 8.73 |
| Magnetic susceptibility (χ) | -10.4 × 10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.497 |
| Dipole moment | 1.1279 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 57.2 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -537.3 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -2221.3 kJ/mol |
| Pharmacology | |
| ATC code | A11AA03 |
| Hazards | |
| Main hazards | May cause respiratory irritation. |
| GHS labelling | GHS07, Exclamation mark |
| Pictograms | GHS07 |
| Signal word | Warning |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | 110 °C |
| Autoignition temperature | 160°C |
| Lethal dose or concentration | LD50 Oral Rat 12,600 mg/kg |
| LD50 (median dose) | LD50 (oral, rat): 12,600 mg/kg |
| NIOSH | VIY |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for L-Valine: "15 mg/m3 (total dust), 5 mg/m3 (respirable fraction) |
| REL (Recommended) | 3.9 g |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds | Norvaline Leucine Isoleucine Valinol |
| Property | Industrial Commentary & Technical Notes |
|---|---|
| Product Name | L-Valine |
| IUPAC Name | (2S)-2-amino-3-methylbutanoic acid |
| Chemical Formula | C5H11NO2 |
| Synonyms & Trade Names | Valine; L-2-amino-3-methylbutyric acid. Industry references may include abbreviations such as L-Val or standard amino acid codes across documentation. No major proprietary trade names established in bulk industrial supply, as specification grading drives differentiation not branding. |
| HS Code & Customs Classification | HS Code allocation typically refers to 2922.41 under amino acids. Customs classification may be cross-referenced under "Amino-acids and their esters, other than those containing more than one kind of oxygen function; salts thereof". Exact classification can depend on regional tariff schedules and specification for food/feed/pharma grade, which customs authorities sometimes verify by grade-specific documentation. |
L-Valine is an essential amino acid produced primarily by microbial fermentation or less commonly by plant extraction routes. Raw material sourcing relies on non-animal feedstocks in most large-scale production to ensure cross-segment acceptance, especially for food, feed, and pharma applications. Fermentation route selection focuses on microbial robustness, yield consistency, by-product minimization, and regulatory acceptance for intended applications.
Physical characteristics—including crystal habit, particulate form, and typical impurity profile—are production route-specific and directly affected by fermentation, extraction, and purification strategies. Industrial process control centers on minimizing isomeric impurities, controlling residual solvents, and maintaining optical (enantiomeric) purity. Grade-dependent properties mainly pursue application-driven specifications; pharmaceutical-grade products demand advanced chromatographic techniques and controlled environments, while feed and technical grades allow broader impurity bands but still focus on reproducibility and batch-to-batch statistical confidence.
Application sensitivity covers much more than purity: even minor process variations (media components, fermentation conditions) can shift impurity types and physical behavior, impacting downstream blending, solubility, and formulation stability—especially for injectable or parenteral forms in pharma. Storage and transport logistics must reflect sensitivity to humidity and microbial contamination, with packaging design often tailored to the grade and distribution channel.
Customs and regulatory compliance for L-Valine requires alignment between declared grade, safety/health documentation, and end-use disclosure. Accurate HS code assignment aligns with documentation required at the border, with manufacturing traceability back to batch-level data (origin, release criteria, impurity documentation) to avoid customs hold-ups or regulatory queries. As a manufacturer, export documentation must be coordinated with internal QA release standards and customer specification sheets. Variation between countries, especially for food and pharma segments, drives the need for active coordination between technical documentation and shipping/logistics departments.
L-Valine is supplied as a crystalline solid. Commercial batches typically range from fine white powder to slightly off-white granules. Odor is nearly absent. Product melting point depends on grade and purity but remains within the expected range for amino acids. Density and particle morphology shift according to synthesis route and drying process, influencing both flowability and blending in downstream processes. These physical characteristics matter in formulation—milling, granulation, and compaction performance all link back to the batch’s physical state. No measurable volatility or flash point under normal handling conditions for this class of solid.
L-Valine remains chemically robust in neutral and slightly acidic or basic solutions at room temperature. Instability may occur under strong oxidizing or prolonged acidic conditions, leading to degradation or racemization, impacting grade suitability for specific nutrition or pharmaceutical purposes. Batch stability traces back to process impurities and post-production handling. Avoid contact with reactive species—chlorinating agents and strong alkalis accelerate side reactions, forming undesired derivatives.
L-Valine dissolves readily in water at ambient temperatures. Solubility profiles differ by grade—feed, pharma, and food grades show minor variance due to trace-level contamination or crystal habit. The dissolution rate affects batching and application integration. Solution preparation for analytical and industrial purposes should follow specified pH and temperature to minimize loss. Precipitation risk rises in high-ionic-strength media, so solutions should be freshly prepared for critical dosing.
Specifications depend on final application. Pharmaceutical and parenteral nutrition grades are subject to stringent identity, assay, and impurity tolerances. Feed and food grades focus on total content and basic impurities. End-use defines acceptable variances in moisture, ash, and enantiomeric purity.
| Parameter | Pharma Grade | Food Grade | Feed Grade |
|---|---|---|---|
| Identity | Confirmed by IR/HPLC | Confirmed by IR | Confirmed by Color Reaction |
| Assay | Grade-specific | Grade-specific | Grade-specific |
| Moisture | Typically lowest | Grade-dependent | Widely variable |
| Impurities | Strict control | Regionally specified | Less stringent |
Impurities derive from raw material selection and reaction scheme. Typical contaminants include related amino acids, organic acids, and trace metals from catalyst residues. Pharma-grade targets the lowest allowable limits; feed grade tolerates higher ranges where safety is demonstrated. Impurity profiles must be monitored by validated analytical methods.
Identity and purity follow chromatographic (HPLC/GC), spectroscopic (NMR, IR), and titrimetric assays. Method selection matches regulatory or customer requirements: pharmacopeial methods for injectable-grade, AOAC or region-specific food/feed analytics as needed. Validation is ongoing and batch-specific calibration is standard in regulated production.
Microbial fermentation and chemical synthesis both see use. Raw materials selection weighs yield, traceability, and regionally regulated input substances. Glucose, ammonia sources, and specialized fermentation media dominate for bio-technical production, while petrochemical feedstocks suit chemical synthesis.
Industry prefers fermentation using genetically selected microbial strains for most regulated grades, targeting high optical purity and low racemate levels. Chemical routes—Strecker synthesis, enzymatic resolution—may apply for technical or feed use. The chosen route influences downstream purification burden and impurity risk.
Key control points center around pH, temperature, oxygen transfer, and real-time optical purity checks. Critical step purification combines ion exchange, activated carbon treatment, and crystallization to remove both systematic and process-borne impurities. Process water quality and reagent handling require tight management to prevent new impurity introduction.
Every batch faces documented, comprehensive QC—chromatographic purity, moisture, residual solvents, endotoxins (if injectable), and bioburden (for bio-derived). Batch-to-batch consistency management hinges on robust traceability of raw materials, in-process critical parameter logging, and end-of-line analytical clearance. The final release standard is subject to internal quality control criteria and customer requirements.
L-Valine’s amine and carboxyl groups participate in peptide bond formation, amidation, esterification, and enzymatic conversion. Side-chain modification runs under controlled conditions for specialty derivatives, like N-protected intermediates in organic synthesis or acylated forms for pro-drugs.
Catalysts, solvent choice, and temperature depend on the end-use reaction. Standard peptide synthesis relies on carbodiimide or phosphonium chemistry at neutral to slightly basic pH. For bulk amidation or esterification, organic solvents or mixed-aqueous systems operate below L-Valine’s decomposition point. Product derivatization may require inert gas protection to limit racemization or side reactions.
Industrially, L-Valine feeds into branched-chain peptide synthesis, pharmaceutical intermediates, and functional food formulations. Batch tailoring and fractionation support customized structure requirements in downstream manufacturing.
Storage temperature, humidity, and atmosphere depend on the grade: pharma and food forms require temperate, low-humidity, light-avoiding environments, with packaging selected for moisture and oxygen permeability control. Feed and technical grades tolerate broader conditions with periodic quality checks. Absence of gas protection may result in slow degradation or caking.
Direct contact with iron and copper accelerates oxidative changes, so most production facilities specify lined drums, PE/PP bags, or composite barrels. Container tightness is important to prevent moisture uptake, especially for high-purity grades.
Shelf life is grade- and storage-dependent. Most pharma and food grades exhibit multi-year stability under defined conditions, subject to regular retest and visual/analytical assessments. Key degradation signs: color change, clumping, reduction in assay by HPLC, presence of unusual odors.
L-Valine generally classifies as non-hazardous in most major regulatory systems when supplied as a pure solid. Granular feed grades may require dust hazard labeling depending on batch particle size and feed additive standards.
Dust inhalation can cause mild, reversible respiratory irritation. Handling bulk powder calls for local exhaust ventilation and dust-minimizing procedures. Spillage on moist surfaces creates slip risks. Skin and eye contact with dust should be rinsed thoroughly as a precaution.
Oral toxicity is low, in line with essential amino acids. Chronic exposure risks have not been found at nutritional intake levels relevant to feed or food use. High-purity pharma batches undergo additional review for residual solvents, trace metals, and microbial specifications as necessary.
No established occupational exposure limits for L-Valine as a pure substance. General practice dictates minimizing airborne particulates, especially in closed plant settings. Personnel must use PPE appropriate for bulk powder handling—nitrile gloves, goggles, dust masks where required by local guidelines. Waste or out-of-spec material disposal follows regional environmental standards and internal protocols to prevent environmental contamination.
L-Valine production capacity depends on current fermentation line output and raw material procurement stability. For common feed-grade or pharma-grade, annual line throughput is directly limited by fermenter batch turnaround speed, feedstock purity, and process uptime. Volumes for feed and technical grades typically meet routine spot and contract volume demands, but pharma- and injectable-grade output requires dedicated purification and analytical release, so slot capacity is adjusted quarterly. Shifts in demand from the animal nutrition and biopharma sectors can create tightness or overhang, especially during high-feed or vaccine seasons.
Standard industrial orders (25 kg–1 MT) ship in typical lead times from 2 to 6 weeks depending on grade, packaging, and current queue. Full-container pharma-grade or specialty packaging can require 6–12 weeks for allocation due to intensified QA testing, documentation, or third-party auditing. MOQs for food and feed grades trend lower, while clinical- or injectable-grade batches are scheduled according to stricter validation and stability criteria, affecting both MOQ and lead time.
Supply form ranges from bulk bags to unitized packs in PE-lined fiber drums, cartons, or specialist high-barrier pouches. Packaging type, liner selection, and sterilization standards shift with grade. Feed and technical uses accept large-format FIBCs; injectable or cell-culture grade requires certified sterile, low-pyrogen packaging, which restricts availability to specific lines and triggers longer cycle times for inventory release.
CIF, FOB, and DAP are available at key ports. Air freight is rare but supported for clinical and research emergencies by prior arrangement. Payment terms track international norms but may shorten for new or high-risk markets. Documentation sails with each batch: lot release, full CoA, and for sensitive grades, batch traceability and auditing files per geographic regulatory need.
Glucose or corn starch drives core input costs for fermentation; access price is most sensitive to regional yields, energy input rates, and logistics. For pharmaceutical grades, downstream costs rise with solvent recovery, multi-step chromatography, and higher analytical throughput. Labor, power costs, and wastewater treatment fluctuate across facilities and directly impact ex-works price. Raw material pricing spikes tend to lag after weather or planting cycle disruptions. For markets linked to cross-border trade, currency volatility and tariff shifts add another layer of unpredictability.
Feed grade prices show the least variance, determined mostly by upstream glucose pricing and basic plant capacity. Food and pharma grade introduce step changes: each purity increment and critical impurity control step adds fixed and marginal costs. The core technical driver of price spread is purification rigour—highly purified injectable or biopharma grades have the largest price gap over animal nutrition grades because of analytical validation, sterile packaging, and documentation requirements. Unit packaging (e.g., high-barrier drum vs. bulk sack) sets further price steps even for identical composition, often in response to downstream customer audit needs or local regulatory demands.
North Asia dominates global output due to raw sugar access, feedstock pricing, and established large-volume fermentation clusters. US and EU capacity is stable but subject to environmental compliance and feedstock price competition with other amino acids. Japan and South Korea prioritize high-purity manufacture, serving the pharma and cell-culture segments. India is a net importer, driven by local demand in animal nutrition and dietary supplements but limited by local fermentation scale.
L-Valine spot prices in the US respond to corn futures and logistics bottlenecks during harvest/export windows. EU prices track energy costs and downstream pharma manufacturing cycles, with temporary upward breaks during regulatory batch holds. China’s market exposes bigger swings due to rapid demand ramp-ups from integrated feed groups and policy-driven export surges. India shows local volatility from currency movements and fluctuating non-GMO demand. Japan trades in stable, low-variance bands, mainly due to tight high-grade process control but has little effect on large-volume pricing.
Forecast price curves for 2026 suggest minor upward pressure if EU and US corn production underperforms, or if Chinese fermentation regulation pushes smaller plants offline. Margin compression will increase if environmental compliance costs outpace plant upgrades. For pharma and specialty grades, price increase is forecast to outstrip feed grade, mostly on the back of deeper documentation and compliance requirements. High-purity and certified grades will continue driving the top band as clinical and cell-culture demand expands.
Pricing and market analysis draws on public corn futures data, OECD grain yield forecasts, industry association surveys, and actual manufacturer tender outcomes. Price forecasting algorithms source multi-year volume trade data, combine historical feedstock input rates for key economies, and weight higher-grade segment premiums according to year-on-year regulatory and downstream compliance signals.
Mergers in Asian fermentation clusters, plant upgrades, and environmental audit outcomes have shifted short-term capacity in 2024. Animal nutrition policy support in Southeast Asia drove a three-quarter demand spike. A producer switch in EU pharma and cell-culture grade sourcing triggered spot shortages on serialized injectable lots.
Tighter import requirements in the US and EU for food- and pharma-grade L-Valine now demand lineage documentation for both raw material and process water sources, particularly for non-GMO claims. China rolled out stricter wastewater discharge parameters, impacting small and cross-contaminated facilities.
Mainstream producers strengthened upstream sourcing contracts for corn/glucose, locked in renewable energy supply to hedge power volatility, and invested in in-line impurity auditing. Dedicated GMP lines now batch-segregate high-purity exports, and multi-continent stock holding improves physical lead times. Real-time batch traceability platforms reduce regulatory audit cycles and improve readiness for new compliance regimes.
L-Valine is produced through either fermentation or synthetic routes, with process choice influenced by raw material costs, impurity profiles, and regulatory expectations for target markets. Our product lines contain food, feed, and pharma grades, each produced under different control regimes. Grade assignment results from consistent QC verification at each batch release.
Feed applications in animal nutrition focus on L-Valine as an essential amino acid supplement, particularly for swine and poultry. Formulators demand stable content with attention to residual sugars and moisture that can affect mixing and storage. Typical feed grades target compliance with large-scale premix production requirements and accommodate regional regulatory tolerances.
Food and beverage applications rely on grades produced with process-water and raw material traceability. Downstream blending sees specifications tightened around pyrogen, heavy metal, and microbial contaminants, since final products undergo minimal processing past this stage.
Pharmaceutical manufacturing sets the most stringent requirements. Both API precursor and excipient uses involve validated processes, equipment validation, GMP lot tracing, and extensive impurity screening. Residual solvents, byproduct amino acids, bioburden, and endotoxins draw closest focus. Pharmacopeial monographs specify minimum testing obligations.
| Application | Recommended Grade | Key Considerations |
|---|---|---|
| Animal Feed Premixes | Feed Grade | Water activity, particle size, residual sugars, batch-to-batch content, regional regulations |
| Food Processing | Food Grade | Pesticide residues, metal content, color, organoleptic purity, allergen traceability |
| Pharmaceuticals (API/Excipient) | Pharma Grade | Impurity profiles, residual solvents, endotoxins, bioburden, full GMP documentation |
Start by clarifying whether the product ends up in feed, food, or pharmaceutical use. Each path determines what risk assessments and downstream customer audits will apply.
Map the application to regional regulatory frameworks—feed uses may demand FAMI-QS, food applications reference Codex/ISO, pharma mandates compliance with pharmacopoeial standards. Standards can define limits for key contaminants and influence sampling frequency, raw material origin, and records retention.
Purity needs will filter out unsuitable grades early. Feed often accepts lower purity with wider impurity spectrum, while pharma specs call for detailed reporting on each detected impurity, with a clear path for out-of-spec remediation. Analytical batch certificates support every critical shipment.
Feed applications often allow for larger pack sizes and less intensive testing per lot, resulting in cost savings at scale. Food and pharma industries regularly require small-batch lots, dual release testing, and batch-specific full traceability, which affect commercial offers.
Validation through customer-formulated trials completes selection. Only in actual use will solubility, compatibility, and stability be fully confirmed. Manufacturers should deliver representative samples with full accompanying analytical records, preferably from actual production-scale lots.
Long-term industrial supply of L-Valine demands a quality system robust enough for consistent batch-to-batch release. Production facilities that focus on pharmaceutical, food, or feed-grade L-Valine maintain certified quality management frameworks, commonly built around ISO 9001 for general manufacturing control. Higher grades intended for regulated industries can require ISO 22000, FSSC 22000, or GMP-based certifications, depending on customer segments. Certification scope is routinely reviewed and updated to reflect regulatory developments and sector-specific audit findings.
For each L-Valine grade, documentation of management system certification accompanies each major production site. Audits—both internal and external—track adherence to defined critical control points, raw material traceability, deviation management, and product authenticity. Inquiries relating to quality system scope, revision history, and audit summary reports can be supported by manufacturer-issued statements rather than generic declarations.
L-Valine intended for food, feed, or pharma applications often falls under additional certification regimes. Feed-grade shipments commonly align with FAMI-QS or HACCP protocols. For nutrition and dietary supplement formulations, Kosher and Halal certificates are typical, though the validity period and certifying agency differ between markets. Some customers, especially in the pharmaceutical segment, request full traceability documentation, DMFs, or regulated notifications depending on the country of import. Organic or non-GMO declarations get issued only after a full audit of the facility’s segregation, process inputs, and cross-contamination strategies.
Each L-Valine batch releases with a manufacturer-issued Certificate of Analysis including values for appearance, assay (by titration or HPLC), moisture, and byproduct controls tied to the specific grade and market. Regulatory-supporting documentation, such as TDS, SDS, and allergen declarations, are updated in cycle with regulatory changes or upon customer request. Systematic sample retention and batch documentation protocols enable retrospective investigation if downstream deviation, reprocessing, or recall emerges at the customer’s site. Validation packages and stability data depend on grade and intended end-use—differing for food additive versus injectable pharmaceutical use.
Manufacturing L-Valine at an industrial scale relies on established fermentation or synthetic routes sized for routine demand and surge requirements during market volatility. Contract buyers, especially those supplying feed, food, or pharma, often request multi-month or annual supply stability backed by manufacturing capacity disclosure. Production variance, maintenance windows, and planned downtime are factored into capacity planning. Flexible cooperation includes volume-based price structuring, rolling forecasts, storage-forward arrangements, and consignment options driven by the customer’s logistics chain or inventory management system.
Core production lines for L-Valine support routine batch manufacturing, process redundancy, and raw material inventory buffering. This approach minimizes impacts from raw feedstock fluctuation, energy disruption, or unexpected demand spikes. For each major grade—feed, food, or pharma—buffer stock and rapid quality-release protocols anchor the ship-out schedule. Customization of the supply model—split deliveries, regional hub warehousing, deferred shipment—matches distributor needs or packaging line availability at the customer’s plant.
Technical sampling uses dedicated pilot-scale or full-scale production lots to ensure customer evaluation aligns with mainline batch characteristics. Request volumes, grade, application context (e.g., finished feed, injectable, nutraceuticals), and documentation requirements (CoA, regulatory, allergen) must be specified in advance. Samples always originate from traceable lots. Batch records, test conditions, and stability data are supplied depending on the end-use requirement. Post-trial technical feedback helps optimize future production or fine-tune purification and packaging parameters.
Business cooperation abides by defined production slots, MOQ terms, and firm forecasting, particularly where integrated supply to contract manufacturers is critical. Non-standard contracting options—including partial-shipment programs, order call-offs, or direct-plant dispatch—mitigate bottlenecks in the customer’s downstream processes. Traceability and rapid lot-release are prioritized in flexible deals, especially where the buyer’s market share depends on uninterrupted flow and timely document provision. Seasonality and regulatory change cycles are considered in volume commitment and risk-shared inventory agreements. For multi-grade portfolios or buyers operating across sectors, bespoke contract terms address grade-specific specification, compliance, and delivery model differences.
In recent years, work on L-Valine has focused on microbial fermentation strain optimization, with R&D teams targeting higher yields and lower by-product formation. Continuous efforts seek to reduce substrate consumption and energy input across strains used for feed, food, and pharmaceutical grades. Innovations in metabolic engineering are driving pathways that minimize impurities like isoleucine or leucine, which commonly arise in traditional production lines. These impurities complicate downstream purification and increase production costs, especially for high-purity applications.
Demand for L-Valine extends beyond classic animal feed and human nutrition. Recent R&D highlights include inclusion in parenteral nutrition, functional food formulations, and cell culture media. Technical requirements shift with each segment. Pharmaceutical and biotech users focus intensely on endotoxin, pyrogen, and heavy metal content, requiring dedicated processing zones and monitoring. The needs of aquaculture and pet nutrition users are driving adjustments in granule size and stability during pelleting or extrusion, which often dictates the upstream drying and crystallization control.
Impurity separation stands as a persistent challenge. Process engineers watch for co-production of structurally related amino acids, which are difficult to separate during crystallization and ion-exchange purification. Advanced membrane filtration and chromatography are now under investigation to enhance separation resolution for pharmaceutical and injectable grades. Automation and real-time analytics integration at critical process points have improved batch-to-batch consistency, especially at industrial scales, but these upgrades require substantial capital investment and upstream integration.
The global demand outlook for L-Valine projects growth tied to rising protein ingredient demand, animal nutrition formulation changes, and regulatory shifts around synthetic amino acid supplementation. Feed-grade volumes remain the backbone of production, but the fastest percentage growth is tied to pharmaceutical and specialty use, given tightening requirements for purity and documentation. Export markets in Asia and South America currently absorb the majority of incremental output, but shifts in regional capacity and raw material economics can significantly affect price stability.
Fermentation yield improvements form the core of process development. Strain evolution efforts include shifting to non-animal, plant-based substrates and even bio-waste streams where permitted, with the goal of lower carbon intensity and reduced process waste. Process intensification through continuous fermentation is gaining traction, though full-scale implementation depends on bioreactor scale-up experience and reliable in-line analytics. Downstream, membrane separation and hybrid purification are replacing batch ion-exchange in select lines, especially where purity targets exceed food-grade specifications.
Many projects invest in water and waste minimization strategies, targeting closed-loop use for non-product-contact streams and valorization of spent biomass. Reagent and solvent choices for downstream processing increasingly follow green chemistry frameworks, guided by international environmental standards or customer-driven audits. The adoption of renewable resource-based feedstocks requires close monitoring of trace contaminants, as variances in raw material quality can introduce batch variability.
Customers can expect direct technical consultation from the manufacturer's application specialists and quality control team. Inquiries regarding impurity profiles, grade compatibility, and interaction with particular matrices (e.g., premix, injection solution, or bioreactor media) are handled by staff experienced with pilot and production-scale challenges. Typical discussions include product release documentation, verification of microbial origin, and clarification of SSCI or allergen status as per customer regulatory environment.
Support extends to formulation review, pilot-scale application testing, and troubleshooting for mixing, flow, or re-crystallization issues. Most application sensitivities relate to grade (feed, food, or injection), particle size distribution, free-flowing properties, and moisture resistance, all of which impact downstream processing such as blending, tableting, or liquid dosing. For high-value applications, technical teams assist with tailored QC protocols that match end-use validation.
All after-sales service is handled internally by subject-matter experts in quality assurance and production, not outsourced or automated. Immediate feedback channels are in place for shipment quality issues, off-spec lots, or compliance documentation discrepancies. Batch records, traceability information, and deviation investigations are provided upon request, subject to customer audit requirements and non-disclosure agreements where applicable. Commitment extends to collaborative investigation of customer-side process deviations if L-Valine is suspected, with on-site support available for large-volume industrial customers.
Our facility produces L-Valine by microbial fermentation using non-GMO raw materials. We manage the entire process internally, from culture development to precise extraction and purification. Automated reactors maintain strict process conditions, ensuring reproducibility from lot to lot. Continuous improvement protocols drive technical refinements, providing a stable supply that meets commercial volume requirements.
Industrial amino acid use continues to expand. L-Valine supports the feed, food, and pharmaceutical industries, supplying core nutritional functions. In feed mills, it enables precise protein balancing in swine and poultry diets, reducing nitrogen emissions and raw material consumption. Food manufacturers use L-Valine to fortify functional products, meeting protein enrichment targets and regulatory compliance. Pharmaceutical formulators require high-purity L-Valine for enteral nutrition blends and intravenous solutions.
Each batch undergoes full-process monitoring with in-house QA analysts performing in-process sampling. Final product testing covers appearance, assay, pH, moisture, ash, and impurity profiles against industry benchmarks. Analytical instrumentation includes HPLC, GC, and ICP-OES, all calibrated according to rigid schedules. Our records match customer batch numbers to in-depth certificates of analysis, simplifying audit trails and regulatory submissions.
Packaging options include fiber drums with food-grade liners, bulk bags, and palletized sacks. Machinery operates under positive-pressure environments to limit contamination. We print full traceability data onto each unit. Finished goods move through temperature-monitored warehouses, and outgoing shipments use industrial logistics partners with real-time tracking. High-volume buyers can stipulate customized packaging and load-planning for automation compatibility.
Our technical team collaborates directly with production engineers, nutritionists, and formulation scientists. Experienced chemists answer product performance inquiries and address process compatibility issues. For new project scale-up, we supply documentation for quality management systems and regulatory registration. Logistic coordinators help manage supply schedules, lead times, and demand surges. Direct technical dialogue minimizes misunderstanding and delivers practical solutions tailored for commercial plants.
Plant managers and procurement teams benefit from short lead times, consistent supply, and analytical transparency. Bulk order contracts lock in long-term pricing stability, supporting budget planning. Distributors and downstream partners leverage our stringent certification to assure their own customers of product reliability. Process data, product origin, and supply volume are verifiable back to our production site. A well-defined management system reduces variability risk, ensuring business continuity and traceable performance for every shipment.
As a direct manufacturer of L-Valine, purity targets shape our process from start to finish. L-Valine that we produce for food and feed applications consistently achieves a minimum purity of 98.5% on a dry basis. We maintain this level by operating under a strict process control regime and by sourcing raw materials that meet internal quality benchmarks. Higher grades, which approach or exceed 99%, are also within our production capabilities, especially for end-uses demanding tighter compositional control. Contaminant limits, particularly for residual solvents and heavy metals, are maintained well below recognized regulatory thresholds.
Quality assurance rests on proven laboratory methods. Our technical team relies on High-Performance Liquid Chromatography (HPLC) as the primary assay method for L-Valine quantification and purity assessment. HPLC separates amino acids with precision, offering reliable results batch after batch. Each batch undergoes extensive documentation, with reference standards and calibration curves checked routinely.
An amino acid analyzer, integrated with post-column ninhydrin derivatization, augments our quality control for specialized customer needs or applications demanding comprehensive profiling. Infrared spectroscopy adds another analytical layer to verify identity and monitor for organic impurities. Moisture content, which factors into purity calculations, is measured by Karl Fischer titration or thermogravimetric methods to ensure accuracy.
Feedback from industrial partners—especially compound feed formulators and food ingredient blenders—drives our emphasis on purity and reproducibility. When purity dips or inconsistency arises, end-user formulations become unpredictable. That impacts nutritional balancing and downstream processing performance. By investing in standardized batch records and robust in-process monitoring, we provide traceable purity documentation for every shipment. Detailed Certificates of Analysis, matching the specific lot delivered, accompany each order.
Challenges occasionally arise in upstream fermentation or during final purification. Our solutions have evolved through hands-on problem-solving: optimizing fermentation media, scaling up refined crystallization procedures, and installing automated in-line detectors. These measures minimize variability and reduce the risk of cross-contamination. Resolving sporadic deviations quickly, we maintain short control loops between the production floor and analytical lab. All corrective actions get logged in internal audits, strengthening long-term quality consistency.
Industrial buyers expect not just a product, but predictability and data transparency to support their own quality programs. Over the years, our plant invested in on-site laboratory upgrades and ongoing analyst training—improving both response speed and analytical reliability. Product recall history remains negligible because we cross-verify every bulk delivery before release. By using robust HPLC assay data as the standard and supplementing it with additional identity and impurity checks, we deliver assurance beyond commodity grade sourcing.
Our commitment does not stop at meeting regulatory requirements. We recognize that every customer’s process interacts uniquely with our L-Valine, so we support technical teams with full assay data, process consultation, and, if required, tailored documentation packages. Transparency builds trust, and trust ensures business continuity for both us and those who rely on our amino acids.
As a direct producer of L-Valine, we have worked with food, feed, and pharmaceutical groups across the globe. Our customers ask about minimum order quantity (MOQ) and packaging every week, as these two points affect procurement planning, warehouse management, and shipping costs. Large-scale L-Valine buyers manage projects involving contract manufacturers, toll processors, and distributors, so getting direct, clear answers from the factory supports good decision-making and cost consistency.
On the production floor, we set the MOQ based on plant batch size, formulation yield, and shipping efficiencies. For L-Valine, our standard MOQ is one full pallet—typically 500 kilograms. This aligns with our continuous production output, packaging operations, and bulk order logistics. Orders below one pallet rarely meet the economics of freight and handling, and no one benefits from excessive broken lots or repacking. We've built our production schedules to meet consistent high-volume demand, so the MOQ secures stable, predictable planning for both us and the buyer.
Years of experience in manufacturing and transoceanic logistics have shown that packaging size can affect product stability, contamination risk, and client convenience. Our standard packaging for L-Valine is a 25-kilogram fiber drum with a polyethylene liner, fully sealed against moisture and contamination. 20- or 25-kilogram kraft paper bags are also widely used, each with an inner PE liner. These formats fit seamlessly into international container loads and standard warehouse racking. Bulk tote bags—also known as FIBCs—have grown in use, especially for very large-scale feed and formulation plants requiring single-drop deliveries of one metric ton per bag. Being the manufacturer, we can pack in custom sizes for strategic customers, as long as it fits within food- and pharma-compliant materials—and makes sense for loading, unloading, and the product’s shelf life.
Optimizing the MOQ and choosing appropriate packaging brings savings to both sides. Bulk orders lower freight rates per kilogram, cut down on warehouse movements, and reduce environmental impact from excess packaging. Our clients expect every drum or bag to maintain the product's free flow and purity up to the point of use, so we measure water activity and seal integrity by batch. The direct factory relationship also allows quick batch turnaround and better transparency on lead times—a critical edge in a rapidly changing market. Packaging flexibility is especially valuable for product development or scale-up trials, where format changes between drum, bag, or tote provide a real-life fit for fill lines and bulk handling systems.
Working factory-direct gets procurement teams quick answers, technical support, and assurance that specs align with regulatory needs. Our technical team can provide detailed breakdowns of packaging support, stacking tolerances, and recommendations for storage. We source liners and drums from certified partners to guarantee compatibility with L-Valine bulk powder, preventing cross-contamination and moisture loss during transport. Over the years, optimizing these practices has cut customer costs, reduced waste, and improved supply chain reliability. For any business looking to secure bulk L-Valine, MOQ and packaging answers from the manufacturer make a measurable difference in project outcomes and operational consistency.
Preserving the purity and physical stability of L-Valine requires a disciplined approach that we enforce throughout our facility. Moisture and heat create significant risks. Unsealed product can absorb water, leading to degradation and clumping, so we manage tight relative humidity controls in our warehouse—never above 60%. We maintain ambient temperatures below 25°C in standard conditions. For longer transits, or if the journey includes warmer climates, temperature logs and insulated containers keep our product protected.
Light can accelerate decomposition in amino acids. For this reason, our technical team recommends complete avoidance of direct sunlight and the use of opaque or UV-blocking bags inside robust packaging drums. The product remains sealed in its original packaging until final formulation to prevent exposure.
Our L-Valine maintains its labeled purity for a minimum of 24 months from the date of manufacture, provided it is handled and stored in the described manner. Routine accelerated and real-time stability studies provide our quality managers with the data to support our claimed shelf life. Each batch undergoes periodic retesting, and we advise customers to request a current certificate of analysis when dispatching international consignments.
Oxidative breakdown poses the greatest risk to shelf life. Nitrogen-flush packaging, which we use for certain export customers, offers further protection against atmospheric oxygen. The outer drums and inner liners all meet international food and pharma transportation requirements.
Clients in pharmaceutical and nutrition sectors depend on reliable production controls and traceability. Our site operates under strict Good Manufacturing Practice (GMP) guidelines. GMP audit schedules, regular staff training, and validated processing lines keep contaminants and mix-ups out of our system. ISO 9001 certification forms the backbone of our quality management, with every critical control step logged and reviewed. Routine external audits strengthen our compliance, reflecting industry expectation for transparency.
For specialized food and pharma markets, we offer batches manufactured under specific regulatory certifications. Our documentation covers itemized trace-element testing, residual solvent analyses, and microbial controls. All lot numbers track back to raw material origin and process equipment logbooks. This tight electronic traceability ensures we satisfy both customer audits and regulator inspections in North America, Europe, and Asia.
Long-haul shipments create special challenges—temperature fluctuations, variable humidity, and extended handling periods. Before each export, our logistics unit evaluates the route’s risk profile. We only release consignments that meet destination-market entry requirements and ensure the paperwork package covers certification, test reports, and handling advice. Stable packaging and rapid movement through bonded customs warehouses prevent cold-chain breaks or damaging delays.
For customers using our L-Valine in injectable pharma or high-purity animal nutrition, we can provide full traceability files and technical support for import documentation. Our direct partnership approach ensures end users receive what our own team would accept for mission-critical production runs.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
